Notice pursuant to Listing Rule 7.12.1
ASX Code: A2M
NZX Code: ATM
Notice pursuant to NZX Main Board Listing Rule 7.12.1
In accordance with NZX Main Board Listing Rule 7.12.1, The a2 Milk Company Limited (ATM) advises that the
following securities have been issued on 13 July 2018:
Class of Security: Performance rights and time-based rights, each
representing an entitlement to acquire ordinary shares
in ATM
ISIN: Not applicable – the rights will not be listed on the NZX
Main Board or the ASX
Number issued: Performance rights – 245,787
Time-based rights – 599,254
Issue price: Not applicable
Payment in cash: Not applicable
Amount paid up (if not in full): Not applicable
Percentage of the total class of securities issued: 8.5% of performance rights; 100% of time-based rights
Reason for issue: The performance rights have been granted to the
incoming Chief Executive Officer of ATM as part of the
on-going long term incentive arrangements that ATM
has adopted to assist in the reward, retention and
motivation of its employees.
The time-based rights have been granted to the
incoming Chief Executive Officer of ATM on a one-off
basis as compensation for forfeitures of her former
employer's short term incentive and long-term incentive
entitlements as a result of her resigning to take up
employment with ATM.
Specific authority for issue: Board resolution
Terms or details of issue: Each performance right and each time-based right is
issued pursuant to the terms and conditions of ATM's
Long Term Incentive Plan (LTIP).
Upon vesting, each performance right and each time-
based right will entitle the holder to one ordinary share
in ATM.
Performance rights: Each performance right includes a
vesting condition that the participant must remain an
Employee (as defined in the LTIP Rules) up to and
including the vesting date (30 June 2021) and that ATM
achieves a compound annual growth rate in diluted
earnings per share (CAGR) from the beginning of the
financial year ending 30 June 2019 to the end of the
financial year ending 30 June 2021 of at least 15%.
ASX Code: A2M
NZX Code: ATM
The proportion of performance rights that will vest will
be determined on a straight-line basis between the
following parameters (rounded down to the nearest
whole number):
• 50% of the performance rights will vest if a CAGR of
15% is achieved; or
• 100% of the performance rights will vest if a CAGR of
25% or more is achieved.
Time-based rights: Each time-based right is not subject
to performance hurdles but includes a vesting condition
that the participant must remain an Employee (as
defined in the LTIP Rules) up to and including one of four
vesting dates during the period from 28 August 2018 to
24 August 2019
Total number of securities of the class
in existence after the issue: 960,000 performance rights issued on 17 August 2015,
895,000 performance rights issued on 8 February 2017,
87,000 performance rights issued on 10 March 2017,
406,000 performance rights issued on 27 September
2017 and 304,200 performance rights issued on 6 March
2018, 245,787 performance rights issued on 13 July 2018
599,254 time-based rights issued on 13 July 2018
Treasury stock (acquisition only): Not applicable
Date of issue: 13 July 2018
Geoffrey Babidge
Managing Director
The a2 Milk Company Limited
+61 2 9697 7000
---
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 1
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12,
04/03/13
Name of entity
The a2 Milk Company Limited
ABN
97 769 415 292
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1
+
Class of
+
securities issued or to
be issued
Performance rights and time-based rights,
each representing an entitlement to acquire
ordinary shares in the entity.
2
Number of
+
securities issued or to
be issued (if known) or maximum
number which may be issued
Performance rights – 245,787
Time-based rights – 599,254
3
Principal terms of the
+
securities
(e.g. if options, exercise price and
expiry date; if partly paid
+
securities, the amount
outstanding and due dates for
payment; if
+
convertible
securities, the conversion price
and dates for conversion)
Each performance right and each time-based
right is issued pursuant to the terms and
conditions of the entity's Long Term Incentive
Plan (LTIP).
Upon vesting, each performance right and
each time-based right will entitle the holder
to one ordinary share in the entity.
Performance rights
Each performance right includes a vesting
condition that the participant must remain an
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 2 04/03/2013
Employee (as defined in the LTIP Rules) up to
and including the vesting date (30 June 2021)
and that the entity achieves a compound
annual growth rate in diluted earnings per
share (CAGR) from the beginning of the
financial year ending 30 June 2019 to the end
of the financial year ending 30 June 2021 of at
least 15%.
The proportion of performance rights that will
vest will be determined on a straight-line basis
between the following parameters (rounded
down to the nearest whole number):
• 50% of the performance rights will vest if a
CAGR of 15% is achieved; or
• 100% of the performance rights will vest if
a CAGR of 25% or more is achieved.
Time-based rights
Each time-based right is not subject to
performance hurdles but includes a vesting
condition that the participant must remain an
Employee (as defined in the LTIP Rules) up to
and including one of four vesting dates during
the period from 28 August 2018 to 24 August
2019.
4
Do the
+
securities rank equally in
all respects from the
+
issue date
with an existing
+
class of quoted
+
securities?
If the additional
+
securities do not
rank equally, please state:
• the date from which they do
• the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest
payment
No.
Any shares issued upon vesting of a
performance right or a time-based right will
rank equally in all respects with the existing
class of quoted ordinary shares from the date
of allotment and issue of those shares.
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 3
5 Issue price or consideration
Nil.
6 Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
The performance rights have been granted to
the incoming Chief Executive Officer of the
entity as part of the on-going long term
incentive arrangements that the entity has
adopted to assist in the reward, retention and
motivation of its employees.
The time-based rights have been granted to
the incoming Chief Executive Officer of the
entity on a one-off basis as compensation for
forfeitures of her former employer's short
term incentive and long-term incentive
entitlements as a result of her resigning to
take up employment with the entity.
6a
Is the entity an
+
eligible entity
that has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the
+
securities the
subject of this Appendix 3B, and
comply with section 6i
No.
6b The date the security holder
resolution under rule 7.1A was
passed
n/a
6c
Number of
+
securities issued
without security holder approval
under rule 7.1
n/a
6d
Number of
+
securities issued with
security holder approval under
rule 7.1A
n/a
6e
Number of
+
securities issued with
security holder approval under
rule 7.3, or another specific
security holder approval (specify
date of meeting)
n/a
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 4 04/03/2013
6f
Number of
+
securities issued
under an exception in rule 7.2
n/a
6g
If
+
securities issued under rule
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
+
issue date and both values.
Include the source of the VWAP
calculation.
n/a
6h
If
+
securities were issued under
rule 7.1A for non-cash
consideration, state date on which
valuation of consideration was
released to ASX Market
Announcements
n/a
6i Calculate the entity’s remaining
issue capacity under rule 7.1 and
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
n/a
7
+
Issue dates
Note: The issue date may be prescribed by ASX
(refer to the definition of issue date in rule 19.12).
For example, the issue date for a pro rata
entitlement issue must comply with the
applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
13 July 2018
Number
+
Class
8
Number and
+
class of all
+
securities quoted on ASX
(including the
+
securities in
section 2 if applicable)
730,039,067 fully paid ordinary shares
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 5
Number
+
Class
9
Number and
+
class of all
+
securities not quoted on ASX
(including the
+
securities in
section 2 if applicable)
9,100,998
3,300,000
1,500,000
960,000
895,000
87,000
406,000
304,200
245,787
599,254
options issued on
17 August 2015 with an
exercise price of NZ$0.63
options issued on
30 March 2015 with an
exercise price of NZ$0.63
partly paid ordinary
shares
performance rights
issued on 17 August 2015
performance rights
issued on 8 February 2017
performance rights
issued on 10 March 2017
performance rights
issued on 28 September
2017
performance rights
issued on 6 March 2018
performance rights
issued on 13 July 2018
time-based rights issued
on 13 July 2018
10 Dividend policy (in the case of a
trust, distribution policy) on the
increased capital (interests)
n/a
Part 2 - Pro rata issue
11 Is security holder approval
required?
n/a
12 Is the issue renounceable or non-
renounceable?
n/a
13
Ratio in which the
+
securities will
be offered
n/a
14
+
Class of
+
securities to which the
offer relates
n/a
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 6 04/03/2013
15
+
Record date to determine
entitlements
n/a
16 Will holdings on different registers
(or subregisters) be aggregated for
calculating entitlements?
n/a
17 Policy for deciding entitlements in
relation to fractions
n/a
18 Names of countries in which the
entity has security holders who will
not be sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
n/a
19 Closing date for receipt of
acceptances or renunciations
n/a
20 Names of any underwriters
n/a
21 Amount of any underwriting fee or
commission
n/a
22 Names of any brokers to the issue
n/a
23 Fee or commission payable to the
broker to the issue
n/a
24 Amount of any handling fee
payable to brokers who lodge
acceptances or renunciations on
behalf of security holders
n/a
25 If the issue is contingent on
security holders’ approval, the date
of the meeting
n/a
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 7
26 Date entitlement and acceptance
form and offer documents will be
sent to persons entitled
n/a
27 If the entity has issued options,
and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders
n/a
28 Date rights trading will begin (if
applicable)
n/a
29 Date rights trading will end (if
applicable)
n/a
30 How do security holders sell their
entitlements in full through a
broker?
n/a
31 How do security holders sell part
of their entitlements through a
broker and accept for the balance?
n/a
32 How do security holders dispose of
their entitlements (except by sale
through a broker)?
n/a
33
+
Issue date
n/a
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34
Type of
+
securities
(tick one)
(a)
+
Securities described in Part 1
(b)
All other
+
securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
securities
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 8 04/03/2013
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35
If the
+
securities are
+
equity securities, the names of the 20 largest holders of the
additional
+
securities, and the number and percentage of additional
+
securities
held by those holders
36
If the
+
securities are
+
equity securities, a distribution schedule of the additional
+
securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37
A copy of any trust deed for the additional
+
securities
Entities that have ticked box 34(b)
38
Number of
+
securities for which
+
quotation is sought
39
+
Class of
+
securities for which
quotation is sought
40
Do the
+
securities rank equally in
all respects from the
+
issue date
with an existing
+
class of quoted
+
securities?
If the additional
+
securities do not
rank equally, please state:
• the date from which they do
• the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest
payment
• the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest payment
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 9
41 Reason for request for quotation
now
Example: In the case of restricted securities, end of
restriction period
(if issued upon conversion of
another
+
security, clearly identify
that other
+
security)
Number
+
Class
42
Number and
+
class of all
+
securities
quoted on ASX (including the
+
securities in clause 38)
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 10 04/03/2013
Quotation agreement
1
+
Quotation of our additional
+
securities is in ASX’s absolute discretion. ASX
may quote the
+
securities on any conditions it decides.
2 We warrant the following to ASX.
• The issue of the
+
securities to be quoted complies with the law and is
not for an illegal purpose.
• There is no reason why those
+
securities should not be granted
+
quotation.
• An offer of the
+
securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able
to give this warranty
• Section 724 or section 1016E of the Corporations Act does not apply to
any applications received by us in relation to any
+
securities to be
quoted and that no-one has any right to return any
+
securities to be
quoted under sections 737, 738 or 1016F of the Corporations Act at the
time that we request that the
+
securities be quoted.
• If we are a trust, we warrant that no person has the right to return the
+
securities to be quoted under section 1019B of the Corporations Act at
the time that we request that the
+
securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.
4 We give ASX the information and documents required by this form. If any
information or document is not available now, we will give it to ASX before
+
quotation of the
+
securities begins. We acknowledge that ASX is relying on
the information and documents. We warrant that they are (will be) true and
complete.
Sign here: ............................................................ Date:
(Director/Company secretary)
Print name:
== == == == ==
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 11
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A
for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid
+
ordinary
securities on issue 12 months before the
+
issue date or date of agreement to issue
n/a
Add the following:
• Number of fully paid
+
ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid
+
ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid
+
ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
n/a
Subtract the number of fully paid
+
ordinary
securities cancelled during that 12 month
period
n/a
“A” n/a
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 12 04/03/2013
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 n/a
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
n/a
“C” n/a
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
n/a
Subtract “C”
Note: number must be same as shown in
Step 3
n/a
Total [“A” x 0.15] – “C” n/a
[Note: this is the remaining placement
capacity under rule 7.1]
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
04/03/2013 Appendix 3B Page 13
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
n/a
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10 n/a
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
n/a
“E” n/a
Appendix 3B
New issue announcement
+ See chapter 19 for defined terms.
Appendix 3B Page 14 04/03/2013
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
n/a
Subtract “E”
Note: number must be same as shown in
Step 3
n/a
Total [“A” x 0.10] – “E” n/a
Note: this is the remaining placement
capacity under rule 7.1A
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- AFT — AFT Pharmaceuticals Limited: NOTICE PURSUANT TO LISTING RULE 7.12.12018-06-14
“15 June 2018 NOTICE PURSUANT TO LISTING RULE 7.12.1 For the purposes of Rule 7.12.1 of the NZX Main Board Listing Rules, AFT Pharmaceuticals Limited (NZX: AFT; ASX:AFP, the “Company”) advises that the following securities have been issued: a) Class of Security I…”
- NZX — NZX Limited: CEO remuneration disclosure2018-05-11
“NZX Limited Level 1, NZX Centre 11 Cable Street PO Box 2959 Wellington 6140 New Zealand Tel +64 4 472 7599 www.nzx.com 11 May 2018 Notice of issue of performance rights which give the holder options to acquire ordinary shares under NZX Limited’s Long Term Incent…”
- ANZ — ANZ Group Holdings Limited: Appendix 3B2018-07-04
“3 Principal terms of the + securities (e.g. if options, exercise price and expiry date; if partly paid + securities, the amount outstanding and due dates for payment; if + convertible securities, the conversion price and dates for conversion) 1…”